148 related articles for article (PubMed ID: 36676150)
21. Chimeric Antigen Receptor T Cells in Large B-Cell Lymphoma: Analysis of Overall Survival Based on Reconstructed Patient-Level Data.
Messori A; Chiumente M; Mengato D
Clin Ther; 2022 Dec; 44(12):1626-1632. PubMed ID: 36503735
[TBL] [Abstract][Full Text] [Related]
22. Distinct molecular profile of IRF4-rearranged large B-cell lymphoma.
Ramis-Zaldivar JE; Gonzalez-Farré B; Balagué O; Celis V; Nadeu F; Salmerón-Villalobos J; Andrés M; Martin-Guerrero I; Garrido-Pontnou M; Gaafar A; Suñol M; Bárcena C; Garcia-Bragado F; Andión M; Azorín D; Astigarraga I; Sagaseta de Ilurdoz M; Sábado C; Gallego S; Verdú-Amorós J; Fernandez-Delgado R; Perez V; Tapia G; Mozos A; Torrent M; Solano-Páez P; Rivas-Delgado A; Dlouhy I; Clot G; Enjuanes A; López-Guillermo A; Galera P; Oberley MJ; Maguire A; Ramsower C; Rimsza LM; Quintanilla-Martinez L; Jaffe ES; Campo E; Salaverria I
Blood; 2020 Jan; 135(4):274-286. PubMed ID: 31738823
[TBL] [Abstract][Full Text] [Related]
23. Prostatic acid phosphatase is a possible tumor marker for intravascular large B-cell lymphoma.
Seki K; Miyakoshi S; Lee GH; Matsushita H; Mutoh Y; Nakase K; Ida M; Taniguchi H
Am J Surg Pathol; 2004 Oct; 28(10):1384-8. PubMed ID: 15371956
[TBL] [Abstract][Full Text] [Related]
24. Burden of Illness and Treatment Patterns in Second-line Large B-cell Lymphoma.
Snider JT; McMorrow D; Song X; Diakun D; Wade SW; Cheng P
Clin Ther; 2022 Apr; 44(4):521-538. PubMed ID: 35241295
[TBL] [Abstract][Full Text] [Related]
25. ALK-positive Large B-cell Lymphoma: A Clinicopathologic Study of 26 Cases With Review of Additional 108 Cases in the Literature.
Pan Z; Hu S; Li M; Zhou Y; Kim YS; Reddy V; Sanmann JN; Smith LM; Chen M; Gao Z; Wang HY; Yuan J
Am J Surg Pathol; 2017 Jan; 41(1):25-38. PubMed ID: 27740969
[TBL] [Abstract][Full Text] [Related]
26. Burkitt lymphoma is immunophenotypically different from Burkitt-like lymphoma in young persons.
Hutchison RE; Finch C; Kepner J; Fuller C; Bowman P; Link M; Schwenn M; Laver J; Desai S; Barrett D; Murphy SB
Ann Oncol; 2000; 11 Suppl 1():35-8. PubMed ID: 10707776
[TBL] [Abstract][Full Text] [Related]
27. Gray-zone Lymphoma Between cHL and Large B-Cell Lymphoma: A Histopathologic Series From the LYSA.
Sarkozy C; Copie-Bergman C; Damotte D; Ben-Neriah S; Burroni B; Cornillon J; Lemal R; Golfier C; Fabiani B; Chassagne-Clément C; Parrens M; Herbaux C; Xerri L; Bossard C; Laurent C; Cheminant M; Cartron G; Cabecadas J; Molina T; Salles G; Steidl C; Ghesquières H; Mottok A; Traverse-Glehen A
Am J Surg Pathol; 2019 Mar; 43(3):341-351. PubMed ID: 30540571
[TBL] [Abstract][Full Text] [Related]
28. Primary central nervous system CD20-negative diffuse large B-cell lymphoma: a case report.
Luo S; Huang X; Li Y; Wang J
BMC Neurol; 2022 Dec; 22(1):504. PubMed ID: 36581860
[TBL] [Abstract][Full Text] [Related]
29. Extranodal Diffuse Large B Cell Lymphoma: Molecular Features, Prognosis, and Risk of Central Nervous System Recurrence.
Ollila TA; Olszewski AJ
Curr Treat Options Oncol; 2018 Jun; 19(8):38. PubMed ID: 29931605
[TBL] [Abstract][Full Text] [Related]
30. Bone Marrow-Liver-Spleen Type of Large B-Cell Lymphoma Associated with Hemophagocytic Syndrome: A Rare Aggressive Extranodal Lymphoma.
Lyapichev KA; Chapman JR; Iakymenko O; Ikpatt OF; Teomete U; Sanchez SP; Vega F
Case Rep Hematol; 2017; 2017():8496978. PubMed ID: 28835859
[TBL] [Abstract][Full Text] [Related]
31. LMO2-negative Expression Predicts the Presence of MYC Translocations in Aggressive B-Cell Lymphomas.
Colomo L; Vazquez I; Papaleo N; Espinet B; Ferrer A; Franco C; Comerma L; Hernandez S; Calvo X; Salar A; Climent F; Mate JL; Forcada P; Mozos A; Nonell L; Martinez A; Carrio A; Costa D; Dlouhy I; Salaverria I; Martin-Subero JI; Lopez-Guillermo A; Valera A; Campo E;
Am J Surg Pathol; 2017 Jul; 41(7):877-886. PubMed ID: 28288039
[TBL] [Abstract][Full Text] [Related]
32. Rare cases of primary central nervous system anaplastic variant of diffuse large B-cell lymphoma.
Xu T; Jia Q; Wang Y; Liu Y; Han D; Li P; Ma J; Fan L; Yan Q; Guo S; Li M; Wang Z
Diagn Pathol; 2019 May; 14(1):45. PubMed ID: 31109360
[TBL] [Abstract][Full Text] [Related]
33. [Primary central nervous system diffuse large B cell lymphoma: a clinicopathologic and molecular study].
Ma ZP; Ainiwaer B; Liu ZY; Shi XL; Cui WL; Zhang W; Li XX
Zhonghua Bing Li Xue Za Zhi; 2016 Nov; 45(11):762-768. PubMed ID: 27821230
[No Abstract] [Full Text] [Related]
34. Adrenal relapse of primary central nervous system diffuse large B-cell lymphoma: A case report.
Ma S; Sen SS; Jug R; Zhang X; Zhang WL; Shen S; Yu CQ; Xu HT; Yang LH; Wang E
Medicine (Baltimore); 2018 Sep; 97(38):e12482. PubMed ID: 30235749
[TBL] [Abstract][Full Text] [Related]
35. Anaplastic Lymphoma Kinase Positive Large B-Cell Lymphoma: Diagnostic Perils and Pitfalls, an Underrecognized Entity.
Chowdhury Z
Cureus; 2021 Aug; 13(8):e16882. PubMed ID: 34513457
[TBL] [Abstract][Full Text] [Related]
36. A Rare Presentation of Primary Central Nervous System Lymphoma in an Immunocompetent Patient.
DeRon N; Ahmed M; Lopez D; Alobaidi A
Cureus; 2022 Apr; 14(4):e23858. PubMed ID: 35530884
[TBL] [Abstract][Full Text] [Related]
37. [Clinicopathological study of large B-cell lymphoma with IRF4 rearrangement].
Chen W; Gong QX; Li X; Song GX; Wang Z; Xu W; Zhang ZH
Zhonghua Bing Li Xue Za Zhi; 2020 Oct; 49(10):1003-1008. PubMed ID: 32992413
[No Abstract] [Full Text] [Related]
38. Primary ALK-Positive Large B Cell Lymphoma of Pancreas.
Kushwaha P; Singh M; Vindal A; Verma N; Jain S
J Gastrointest Cancer; 2022 Sep; 53(3):830-833. PubMed ID: 34374890
[TBL] [Abstract][Full Text] [Related]
39. [Primary lymphoma of breast: a clinicopathologic and prognostic study of 40 cases].
Yang H; Lang RG; Liu FF; Wang XF; Jin ZJ; Lü AJ; Wang Y; Fu XL; Fu L
Zhonghua Bing Li Xue Za Zhi; 2011 Feb; 40(2):79-84. PubMed ID: 21426801
[TBL] [Abstract][Full Text] [Related]
40. The immune contexture of primary central nervous system diffuse large B cell lymphoma associates with patient survival and specific cell signaling.
Alame M; Cornillot E; Cacheux V; Rigau V; Costes-Martineau V; Lacheretz-Szablewski V; Colinge J
Theranostics; 2021; 11(8):3565-3579. PubMed ID: 33664848
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
